A Clearinghouse for Information about Blood Clots (DVT/)PE) and Clotting Disorders (thrombophilia) provided as a public service by the University of North Carolina Blood Research Center

Tag: DVT prevention

Xarelto (Rivaroxaban) – FDA Approved

On July 1st, the FDA approved the oral blood thinner Xarelto (rivaroxaban) for the prevention of deep vein thrombosis (DVT) in patients undergoing knee or hip replacement surgery.

July 1, 2011

Tag: DVT prevention

Xarelto (Rivaroxaban) – FDA Approved